Literature DB >> 33415064

A Case Report of Babesiosis Seen Outside of its Endemic Area and Incubation Period.

Jinal K Patel1, Kiran Tirumalasetty1, Bassem Zeidan1, Parth Desai2, Johnathan Frunzi1.   

Abstract

Babesia microti is a parasitic alveolate that is usually transmitted by Ixodes scapularis tick, which also transmits Lyme disease. Babesiosis is endemic in the Northeast and Upper Midwestern regions of the United States. This case report illustrates a 29-year-old Hispanic male who presented to a Florida hospital emergency department with complaints of fever, generalized weakness, and flu-like symptoms over a duration of four days. Subsequently, he was diagnosed with babesiosis infection since he had a travel history to Cape Cod, Massachusetts about 10 weeks before presenting to the hospital. He was treated with atovaquone, clindamycin, and azithromycin. The importance of this report is to illustrate that babesiosis may occur outside its endemic area and incubation period.
Copyright © 2020, Patel et al.

Entities:  

Keywords:  babesiosis microti; endemic in northeast and upper midwestern; infectious and parasitic diseases; ixodes scapularis tick; malaria like symptoms; maltese cross; non-endemic region; splenectomy; tick-borne infections

Year:  2020        PMID: 33415064      PMCID: PMC7781866          DOI: 10.7759/cureus.11926

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  3 in total

1.  First case of (imported) babesiosis diagnosed in Canada.

Authors:  D Kunimoto; K Krause; D Morrison
Journal:  Can J Infect Dis       Date:  1998-11

2.  Human babesiosis.

Authors:  Edouard Vannier; Peter J Krause
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

3.  Case report of the patient source of the Babesia microti R1 reference strain and implications for travelers.

Authors:  Philipp Stahl; Yves Poinsignon; Pascal Pouedras; Vasilica Ciubotaru; Laurence Berry; Brinda Emu; Peter J Krause; Choukri Ben Mamoun; Emmanuel Cornillot
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.